Keytruda Post-Launch Patient Website

Mar 10, 2018Mar 6, 2018

Brand: Keytruda (pembrolizumab), Injection
Parent Company: Merck
Drug Type: Prescription
Drug Category: Oncology
Campaign: Post-Launch
Targeting: Patients, Caregivers
Patient Website: https://www.keytruda.com/
HCP Website: https://www.keytruda.com/hcp/

: Homepage

: Level 1 Page

: Patient Stories

: Patient Story

: Homepage (Mobile)

: Level 1 Page (Mobile)